Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
Clinical trial NCT04676243 · WITHDRAWN
Trial details
- NCT number
- NCT04676243
- Sponsor
- University Hospital Heidelberg
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2025-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.